and ventilation and obviated the need for longterm endotracheal intubation and tracheostomy. We present a case of a child with obstructive sleep apnoea relieved with nasal CP AP and a case of an adolescent with central alveolar hypoventilation treated with nocturnal nasal ventilation -in both cases delivered by custom-made masks. Case J A seventeen-month-old girl weighing 11 kg with achondroplasia and hydrocephalus presented with inspiratory stridor and cyanosis. The haemoglobin oxygen saturation measured using pulse oximetry was 50-60% during sleep. Arterial blood gas analysis, with oxygen therapy, yielded a P a02 of 50 mmHg. p aC02 63 mmHg and a base ,excess of 1 O. 7 mmolll.
Obstructive sleep apnoea had been recognised previously for which she had undergone adenotonsillectomywithout significant benefit one month prior to this admission. In addition, there was a prior history of viral pneumonia and residual bronchiolitis obliterans for which she required constant intranasal oxygen therapy of 1-2 lImin. Two weeks prior to admission, insertion of a nasopharyngeal tube had been necessary to relieve obstruction of the upper airway after a general anaesthetic for a cranial CT scan which had been performed to exclude compression of the hindbrain with vagal nerve involvement as the cause of stridor.
Prior to this admission, the child had spent most of her life in hospital for the treatment of hydrocephalus, lung disease and chronic obstructive sleep apnoea. Moreover, electrocardiographic and echocardiographic investigations on this admission revealed evidence of right heart hypertrophy, presumably due to chronic hypoxaemia. To prevent further cardiac damage and to facilitate her discharge from hospital, an effective treatment of the obstructive sleep apnoea was deemed necessary. A custommade nasal mask was fashioned. CP AP of 8 cm H 2 0 with 40% oxygen was provided with a Sullivan CPAP system (ResCare, Sydney, Australia). The signs of obstruction and hypoxaemia during sleep were relieved and she was discharged home. Follow-up clinical examination at two months did not reveal evidence of right heart strain.
ease 2
A fifteen-year-old girl with spina bifida, but previously ambulant, presented with walking difficulty, nystagmus, seventh nerve palsy and daytime somnolence. A CT scan revealed an Arnold-Chiari type 11 malformation with hydrocephalus and a syrinx extending from high cervical to low thoracic vertebrae. She underwent a posterior fossa decompression and insertion of a ventriculo-peritoneal shunt with subsequent amelioration of the signs attributable to cranial nerve and long tract compression. However, her daytime somnolence worsened and her sleep was disturbed by frequent arousal. Episodes of nonobstructive hypoventilation lasting up to one minute with a respiratory rate of two to four breaths and cyanosis were also observed during sleep. (In retrospect, there had been a history, extending over twelve months, of nocturnal insomnia and daytime somnolence.) Pulse oximetry revealed long periods of desaturation (Sp02 50-60%). She was treated with oxygen (4 lImin by face mask) with some improvement. End-tidal carbon dioxide levels varied between six and nine and a half per cent. On one occasion, she appeared comatose during which arterial blood gas analysis confirmed a state of chronic respiratory acidosis {P aco2 101 mmHg, P a02 64 mmHg, base excess 10.7 mmolll). She was awakened by bag and mask ventilation. Arterial blood gas analysis while she was awake revealed a PaC02 of 49-53 mmHg.
A custom-made nasal mask was fashioned. Nocturnal mechanical ventilation with air was provided with a Bear 33 portable ventilator at 12 breaths/min in an IMV (intermittent mandatory ventilation) mode. The tidal volume was adjusted to an end-tidal carbon dioxide level of 5.0-5.5% and oxygen saturation measured by pulse oximetry of 95%. With mechanical ventilation, her sleep became restful and undisturbed and she remained alert throughout the day. She was discharged home and has been attending school for three months.
MASK AND CIRCUIT CONSTRUCTION
The custom-made mask was popularised at the International Conference on Home Ventilation staged in Lyon, France in January 1989. The mask is constructed from a kit (,Nasal Pack') of materials provided by Laboratoire CAIR (6, Rue de l'Union, 69170 Tarare, France) and demonstrated by the not-for-profit regional organisation ALLP (Association de la Region de Lyon Pour la Lutte Contra la Poliomyelite) formed originally to help polio survivors. The components of the kit are silicone paste and hardener (a catalyst), thermoplastic splinting material, reinforced silicone tubes, headstraps and aY-connector. The materials may however be assembled from local sources.
The mask is constructed of silicone and is moulded from the patient's nose. Construction of the mask is usually an outpatient procedure although general anaesthesia via an oropharyngeal airway or endotracheal intubation is required for small unco-operative children, as it was for our seventeen-month-old patient. The patient lies in a supine position, the technician standing behind. Silicone paste and hardener are blended to a uniform mixture. The mixture is applied over the nose, including the bridge and nostrils, and over the adjacent cheek and upper lip regions. This impression becomes the mask. After two minutes, the mixture begins to harden and may be removed from the face after four to five minutes. After twenty minutes, the mask can be worked. The edges and the posterior indentations of the nasal fossae are trimmed off and two holes are drilled through the mould to match the patient's nostrils. The diameter of the holes must be two to three millimetres less than the external diameter of the tubes to be inserted. The kit contains two tubes of which the internal diameters are 5 mm and external diameters 8 mm. However, any spiral-wire reinforced endotracheal tubes will suffice. We utilised 4.0 mm reinforced silicone endotracheal tubes for our seventeen-month-old patient.
The distal ends of the tubes are pushed through the nostril apertures of the mask and rotated so that the bevels intrude one to two millimetres into the nostril entrances. After checking that the mask fits snugly over the nose and the tubes are well positioned, the thermoplastic splinting material is moulded over the outer surface of the mask. This consolidates the mask, secures the tubes and affords anchorage points for the head straps or harness. Construction time for the mask is about one hour. It is necessary to construct a new mask every three to five months.
Head straps (brassiere straps) are passed above and below the ears and are attached to boles drilled in the outer thermoplastic shell. Alternatively, a harness may be constructed with the occipital cap to help secure the mask on the nose as we did for our fifteen-year-old patient. The free ends of the tubes are attached to the ventilator or CP AP device by a Y-connector. For mechanical v~ntilation, an expiratory valve is inserted into the ventilator circuit close to the Y-connector. A chin-strap may be added to ensure mouth closure and to limit air leak. The required tidal volume may be several times that required in the intubated patient to compensate for leaks and high compliance of the circuit and upper airway. 1 A high-pressure-limiting device must be incorporated to prevent pulinonary barotrauma and gastric distension. The latter _may occur when the laryngeal inlet is closed during normal deglutition of saliva during sleep. The mask must be comfortable and exert no localised pressure. Periodic checks should be made of the nasal bridge, the gums and the nostrils. Protrusions on the mask may be sanded back. Breathing through the system should be free with the mouth closed. A mask and proximal part of the circuit are illustrated in Figure 1 .
Airway patency may be a problem during upper respiratory tract infection. Use of a topical sympathomimetic agent may be necessary to reduce secretion and oedema.
DISCUSSION
Treatment of obstructive sleep apnoea includes the options of permanent tracheostomy, adenotonsillectomy, pharyngoplasty or intermittent nasopharyngeal tube insertion. Reversal of obstructive sleep apnoea by CP AP applied to the nasopharynx by a nasal mask was first described in 1981. 2 The efficacy of the nasal CP AP mask led to the application of intermittent positive pressure ventilation to treat nocturnal hypoventilation in adults with neuromuscular diseases 3 -5 and to treat respiratory failure in adults with restrictive or obstructive lung disease 6 • 7 without the need for endotracheal intubation or tracheostomy ('noninvasive'). More recently, nasal mask ventilation has been used to treat nocturnal hypoventilation in children with Werdnig-Hoffmann disease, Duchenne muscular dystrophy and congenital myopathy.s An integral part of the provision of noninvasive CP AP or mechanical ventilation -a suitable mask -has been manufactured commercially for adults (Respironics Inc., Monroeville, Pennsylvania, U.S.A.; ResCare, Sydney, Australia). However, a custom-made mask is preferable and one type using silicone paste has been described for adults 9 and is easily adapted to children. The silicone mask is comfortable, well accepted, has an efficient seal, does not cause pressure-related lesions and may be constructed individually for each patient.
Respiratory Arrest During Epidural Infusion of Bupi vacaine and Fentanyl
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Key Words: ANALGESIA: postoperative, epidural bupivacaine, fentanyl; COMPLICATIONS: respiratory arrest Combined epidural infusion oflocal anaesthetics and opioids has been proposed for postoperative analgesia. 1 Fentanyl is favoured as an epidural opioid because it has high lipid solubility and is considered unlikely to cause delayed respiratory depression. 2 -4 This report outlines three cases of respiratory arrest during epidural infusion of bupivacaine and fentanyl.
Case 1
A 64-year-old, 81 kg man, ASA physical status Ill, presented with a malignant atypical carcinoid tumour of the left lower lobe bronchus. His past history included essential hypertension, cerebral arterial disease and uneventful, unrelated surgery. A cerebral CT scan was negative.
Preoperative treatment included the use of salbutamol and beclamethasone inhalers, methyldopa 250 mg bd, and oral prednisone 30 mglday.
Premedication included papaveretum 15 mg and scopolamine 0. Accepted for publication November 26, 1990 fentanyl 25 fJ.glml was injected through an epidural catheter inserted at the T 6/7 interspace. The infusion was continued at a rate of 4 ml per hour, anaesthesia maintained with enflurane in oxygen, and a left pneumonectomy was performed without complication.
Five hours after surgery the rate of epidural infusion was increased, because of pain, to 5 ml/hr (bupivacaine 10 mg and fentanyl 125 fJ.g per hour). After this the patient was consistently pain-free, drowsy, but easily rousable to voice, with a respiratory rate between 18 and 22 per minute.
Seventeen hours after surgery, the patient was found unconscious, unresponsive, dusky, with an obstructed airway and feeble respiratory efforts. Sinus rhythm was present, with an arterial pressure of 110/80 mmHg. Following resuscitation with bag and mask ventilation the patient had a spontaneous respiratory rate of eight per minute but was still unconscious. Following naloxone 0.2 mg IV the patient awoke with a respiratory rate of twelve per minute.
The epidural infusion was continued at a reduced rate (1-2 mlIhr) until 46 hours after surgery when apnoeic spells of up to ten seconds were observed despite a basic respiratory rate of fourteen per minute.
